Abbott UK
Presence
Abbott is one of the...
Abbott is a company listed under the stock ticker ABT (US).
Abbott has a direct presence in 16 countries.Abbott has 22 subsidiaries including Abbott Americas, Abbott ANZ and Abbott APAC.
They are in:
- Pharmaceuticals74%
- Biotechnology13%
- Other13%
Acquisition, funding and merger involving Abbott.
- Abbott has announced the acquisition of Cardiovascular Systems (posted on February 13 2023).
Executives
View the org chart displaying its 3 main executives
Most searched biographies at Abbott UK
- Gulberk Kavsuk, General Manager, Abbott Nutrition
- Mike Clayton, General Manager, International Toxicology
- Stéphane Sarrazin, Director, International Executive Recruitment ...
Create your alert
to follow the executive moves at Abbott UK.
Pharmaceuticals
Abbott has 1,869 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Abbott UK
- Abbott UK | Real-World Data Show Abbott’s FreeStyle Libre Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
- Abbott UK | Abbott introduces first ever consumer biowearable, Lingo™, set to re-energise the nation
- Abbott UK | New Real-World Data Shows Abbott’s FreeStyle Libre® Technology Delivers Significant Health Benefits For People with Type 2 Diabetes
- Abbott UK | New Update to Abbott’s FreeStyle LibreLink App Enables People Using FreeStyle Libre® 2 System to Receive Automatic Glucose Readings Every Minute
- Abbott UK | Key Diabetes Players Abbott, Ypsomed and CamDiab Join Forces in the UK to offer Hybrid Closed Loop System with More Affordable Sensor Technology
- Abbott UK | Over A Third Of Brits In The Dark Over When Antibiotics Are Needed, New Abbott Survey Reveals
- Abbott UK | Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition
- Abbott UK | Abbott Launches New Integrated Digital Solution for People with Diabetes in the UK
- Abbott UK | The UK’s First Remote Neuromodulation Patient-Care Technology From Abbott Now Available In Key Centres Across Country
- Abbott UK | New Data Shows That Abbott’s FreeStyle Libre® System Reduces Diabetes-related Hospitalisations for People with Type 2 Diabetes on Once-daily Insulin Therapy
- View more press releases Close
Social media about Abbott UK
- Abbott UK on Wikipedia, Google News & Yahoo Finance
- Abbott UK on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Stéphane Sarrazin 
